Jordan Dunitz is a Respiratory physician affiliated with University of Minnesota. OpenAlex indexes 106 publications with 5,304 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Minnesota Physicians
516 Delaware Street SE, Pwb Second Floor, Clinic 2a
Minneapolis, MN 55455
Telephone
612-626-6100Registry record last updated 25 Oct 2012.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20221 payment
- Insmed, Inc.Program year20212 payments
- Vertex Pharmaceuticals IncorporatedProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
25.8%Proton pump inhibitor9.1%Pantoprazole Sodium62%Omeprazole31%Rabeprazole Sodium7%Part D<11 patientsCorticosteroid8.1%Prednisone100%Part D≥38 patients+ 6 more classes in this area
Anti-infectives
24.4%Macrolide Antimicrobial9.1%Azithromycin100%Part D≥34 patientsShort-acting sulfonamides7%Sulfamethoxazole-Trimethoprim100%Part D≥34 patients+ 8 more classes in this area
Cardiovascular
15.7%Beta blocker7.1%Metoprolol Tartrate51%Carvedilol37%Metoprolol Succinate12%Part D<11 patientsCalcium channel blocker3%Amlodipine Besylate81%Diltiazem 24hr Er19%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2009 per NIH RePORTER. The latest:
- A PHASE 3, INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTRO
University of Minnesota
FY2009$9,147M01RR000400 - 08-108: DENUFOSOL TETRASODIUM INHALATOIN SOLUTION IN MILD CF LUNG DISEASE
University of Minnesota
FY2009$5,489M01RR000400 - A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VX-770 TO EVAL
University of Minnesota
FY2009$1,830M01RR000400
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”